Mercer Global Advisors Inc Biomarin Pharmaceutical Inc Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

A detailed history of Mercer Global Advisors Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mercer Global Advisors Inc holds 8,188 shares of BMRN stock, worth $545,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,188

Previous 12,168 32.71%

Holding current value

$545,566

Previous $1 Million 42.56%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $274,699 - $373,483	-3,980 Reduced 32.71%	8,188 $575,000
Q2 2024 Aug 12, 2024	SELL	$74.43 - $92.22 $7,740 - $9,590	-104 Reduced 0.85%	12,168 $1 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $22,042 - $26,037	-263 Reduced 2.1%	12,272 $1.07 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $13,719 - $17,731	-180 Reduced 1.42%	12,535 $1.21 Million
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $241,513 - $268,228	-2,839 Reduced 18.25%	12,715 $1.13 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $5,200 - $6,018	-60 Reduced 0.38%	15,554 $1.35 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $59,575 - $79,626	-679 Reduced 4.17%	15,614 $1.52 Million
Q4 2022 Feb 08, 2023	SELL	$80.93 - $108.63 $129,002 - $173,156	-1,594 Reduced 8.91%	16,293 $1.69 Million
Q3 2022 Nov 15, 2022	SELL	$82.16 - $96.94 $122,089 - $144,052	-1,486 Reduced 7.67%	17,887 $1.52 Million
Q2 2022 Aug 10, 2022	BUY	$71.48 - $86.85 $1,143 - $1,389	16 Added 0.08%	19,373 $1.61 Million
Q1 2022 May 10, 2022	SELL	$74.28 - $92.69 $519 - $648	-7 Reduced 0.04%	19,357 $1.49 Million
Q4 2021 Feb 04, 2022	BUY	$71.72 - $91.47 $44,107 - $56,254	615 Added 3.28%	19,364 $1.71 Million
Q3 2021 Nov 10, 2021	SELL	$74.77 - $85.47 $401,888 - $459,401	-5,375 Reduced 22.28%	18,749 $1.45 Million
Q2 2021 Aug 10, 2021	SELL	$75.51 - $84.79 $4,606 - $5,172	-61 Reduced 0.25%	24,124 $2.01 Million
Q1 2021 Aug 10, 2021	BUY	$74.73 - $90.69 $22,792 - $27,660	305 Added 1.28%	24,185 $1.83 Million
Q1 2021 May 11, 2021	SELL	$74.73 - $90.69 $200,650 - $243,502	-2,685 Reduced 10.11%	23,880 $1.8 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $22,799 - $28,322	314 Added 1.2%	26,565 $2.33 Million
Q3 2020 Dec 10, 2020	BUY	$71.87 - $131.03 $1.68 Million - $3.06 Million	23,384 Added 815.63%	26,251 $2 Million
Q2 2020 Aug 10, 2020	BUY	$79.55 - $124.22 $2,704 - $4,223	34 Added 1.2%	2,867 $354,000
Q1 2020 May 18, 2020	BUY	$71.37 - $96.85 $999 - $1,355	14 Added 0.5%	2,833 $239,000
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $181,177 - $243,477	2,819 New	2,819 $238,000
Q3 2019 Nov 12, 2019	SELL	$67.4 - $85.11 $183,665 - $231,924	-2,725 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $6,749 - $7,887	84 Added 3.18%	2,725 $233,000
Q1 2019 Apr 23, 2019	SELL	$84.2 - $98.62 $71,233 - $83,432	-846 Reduced 24.26%	2,641 $235,000
Q1 2019 Apr 12, 2019	BUY	$84.2 - $98.62 $293,605 - $343,887	3,487 New	3,487 $297,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Biomarin Pharmaceutical Inc Transaction History